Last $176.65 USD
Change Today +6.22 / 3.65%
Volume 881.5K
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Seamus C. Mulligan

AgeTotal Calculated CompensationThis person is connected to 14 board members in 4 different organizations across 4 different industries.

See Board Relationships
54--

Background*

Mr. Seamus C. Mulligan serves as the Chief Executive Officer and Chairman of Adapt Pharma. Mr. Mulliganalso founded Adapt Pharma in 2013. Mr. Mulligan served as Chief Business Officer of International Business Development at Jazz Pharmaceuticals plc from January 2012 to February 2013 and served as its Head of Corporate Development. Mr. Mulligan served as the Chief Executive Officer of Jazz Pharmaceuticals Plc (formerly Azur Pharma Limited). He served as Executive Vice ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 634 7800
Fax: --

Board Members Memberships*

Director
Director
Chief Executive Officer and Chairman
2012-Present
Director

Education*

MS
Trinity College
BS
Trinity College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JAZZ:US $176.65 USD +6.22

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JAZZ PHARMACEUTICALS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.